Crossmark

The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology

Published Online: 2024-11-06

Authors

Ameya, K. P.

Sekar, Durairaj
License Information

Text and Data Mining valid from 2024-11-06

Version of Record valid from 2024-11-06
More Information

Article History

Received: 29 October 2024

Accepted: 1 November 2024

First Online: 6 November 2024

Declarations

:

: The authors declare no competing interests.

: Not applicable.

Document is current